We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more OK
Roche Menu Search Global Web Site : Investors

You are here:

  1. Investors
  2. IR events
Roche
  • Home
  • About Roche
  • Sustainability
  • Research & Development
  • Partnering
  • Media
  • Investors
  • Careers
  • Products
  • Investor updates
  • IR events
  • Share Information
  • Annual Report 2020
  • Historic quarterly reporting
  • Finance information tool
  • Pipeline
  • Diagnostics news
  • Sustainability download center
  • Dividend calendar
  • Total return center
  • Frequently asked questions
  • US investors
  • Contacts

Roche investor conference call on the acquisition of InterMune

Monday, 25 August

Conference call to discuss the announcement that Roche (SIX: RO, ROG; OTCQX: RHHBY) and InterMune, Inc. (NASDAQ: ITMN) have entered into a definitive merger agreement for Roche to fully acquire InterMune.

The conference call has ended.

Share
  • Share via email
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Google+
  • Share on Xing
Close

Related links

  • Corporate Governance
  • Annual Report
  • Pipeline
  • FAQ

Service

  • Investor Relations team
  • Send e-mail
  • Subscribe to Roche News
  • Roche Finance Information System

Additional Information

  • Investor Update

Downloads

  • Presentation slides
  • © 2021 F. Hoffmann-La Roche Ltd
  • 16.04.2021
  • Legal Statement
  • Privacy Policy
  • Cookie Settings

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

  • LinkedIn
  • Facebook
  • Pinterest
  • Twitter
  • YouTube